Zhangzhou Pientzehuang Pharmaceutical Co Ltd Class A 600436
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 242.80
- Day Range
- CNY 237.60–243.18
- 52-Week Range
- CNY 180.69–315.98
- Bid/Ask
- CNY 0.00 / CNY 0.00
- Market Cap
- CNY 143.40 Bil
- Volume/Avg
- 1.4 Mil / 1.9 Mil
Key Statistics
- Price/Earnings (Normalized)
- 46.78
- Price/Sales
- 13.52
- Dividend Yield (Trailing)
- 0.53%
- Dividend Yield (Forward)
- 0.53%
- Total Yield
- 0.53%
Company Profile
Zhangzhou Pientzehuang Pharmaceutical Co Ltd produces and sells Chinese medicines. The company's product categories include drugs and healthcare products, healthy foods, cosmetics, daily chemicals, and medical instruments. Some of its products include Xinshubao Tablet, Yindan Pinggan Capsule, Liuwei Dihuang Pills, and Chuangbei Qingfei Syrup.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Large Growth
- Total Number of Employees
- 2,720
- Website
- http://www.zzpzh.com
Comparables
Valuation
|
Metric
|
600436
|
600518
|
600285
|
|---|---|---|---|
Price/Earnings (Normalized) | 46.78 | — | 24.72 |
Price/Book Value | 10.00 | 3.81 | 4.96 |
Price/Sales | 13.52 | 4.16 | 4.23 |
Price/Cash Flow | 68.12 | — | 18.71 |
Price/Earnings
600436
600518
600285
Financial Strength
|
Metric
|
600436
|
600518
|
600285
|
|---|---|---|---|
Quick Ratio | 1.13 | 0.80 | 1.02 |
Current Ratio | 5.27 | 1.48 | 1.33 |
Interest Coverage | 97.56 | 3.31 | — |
Quick Ratio
600436
600518
600285
Profitability
|
Metric
|
600436
|
600518
|
600285
|
|---|---|---|---|
Return on Assets (Normalized) | 18.63% | −4.99% | 12.44% |
Return on Equity (Normalized) | 23.64% | −10.43% | 21.12% |
Return on Invested Capital (Normalized) | 20.90% | −9.72% | 19.26% |
Return on Assets
600436
600518
600285
Drug Manufacturers - General Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
LLY
| Eli Lilly and Co | Msdwynrdtd | Xsn | $726.1 Bil | |
JNJ
| Johnson & Johnson | Nnrzttkqk | Kylvy | $363.9 Bil | |
MRK
| Merck & Co Inc | Lcxkjsg | Sxby | $325.9 Bil | |
ABBV
| AbbVie Inc | Tnxbbltr | Wdql | $285.3 Bil | |
AZN
| AstraZeneca PLC ADR | Tdkfzclvzg | Gjg | $238.5 Bil | |
NVS
| Novartis AG ADR | Mtcyvfb | Jhvj | $209.5 Bil | |
RHHBY
| Roche Holding AG ADR | Rsxzxcvf | Lsw | $202.8 Bil | |
AMGN
| Amgen Inc | Wkxzzfgbfx | Cjmx | $167.1 Bil | |
PFE
| Pfizer Inc | Trbmmkcw | Jwtq | $160.8 Bil | |
SNY
| Sanofi SA ADR | Bbyskftnt | Wkdq | $124.8 Bil |